Specifically, research has highlighted that the degradation of perlecan-Sema3A-PlexinA1-Nrp1 receptor complexes on prostate cancer cells by MMP7 regulates tumour cell migration by destabilising cell junctions [24, 25]. This evidence concerns the gene SEMA3A and neoplasm.